Charles Langelier, Victoria Chu, Abigail Glascock, Deborah Donnell, Cole Grabow, Clare Brown, Ryan Ward, Christina Love, Katrina Kalantar, Stephanie Cohen, Chase Cannon, Michael Woodworth, Colleen Kelley, Connie Celum, Anne Luetkemeyer
Doxycycline post-exposure prophylaxis (doxy-PEP) reduces bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women. While poised for widespread clinical implementation, the impact of doxy-PEP on antimicrobial resistance remains a primary concern as its effects on the gut microbiome and resistome, or the antimicrobial resistance genes (ARGs) present in the gut microbiome, are unknown. To investigate these effects, we studied participants from a randomized clinical trial who either received doxy-PEP as a one-time doxycycline 200 mg taken after condomless sex (DP arm, n = 100) or standard of care treatment (SOC arm, n = 50)...
April 17, 2024: Research Square